Hansoh Pharma, Hongqiao tap Asia CB market

Hong Kong-listed Hansoh Pharmaceutical Group and China Hongqiao Group have added to the burst of convertible bond activity in the first week of 2021, raising a combined $900m from the equity-linked market on Thursday.

Read Previous

Gracell Biotech boosts US IPO size to $209m

Read Next

Spain set to make green bond debut in 2021

Most Popular

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.